Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

argx

POPULAR ARTICLES

argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG

biotech-investing

argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG

argenx Highlights 2026 Strategic Priorities

biotech-investing

argenx Highlights 2026 Strategic Priorities

argenx to Present at 44th Annual J.P. Morgan Healthcare Conference

biotech-investing

argenx to Present at 44th Annual J.P. Morgan Healthcare Conference

LATEST ARTICLES

argenx Announces Leadership Transition Marking Next Evolution of Growth

biotech-investing

argenx Announces Leadership Transition Marking Next Evolution of Growth

argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease

biotech-investing

argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease

argenx Announces Results of Extraordinary General Meeting of Shareholders

biotech-investing

argenx Announces Results of Extraordinary General Meeting of Shareholders

argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada

biotech-investing

argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada

argenx Reports Third Quarter 2025 Financial Results and Provides Business Update

biotech-investing

argenx Reports Third Quarter 2025 Financial Results and Provides Business Update

argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients

biotech-investing

argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients

argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025

biotech-investing

argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025

argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025

biotech-investing

argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025

Latest News

CORRECTION - Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound

Purpose Investments Announces Implementation of Staking in Purpose Ether ETF

Top 5 Canadian Mining Stocks This Week: Euro Manganese Gains 134 Percent

RAB Capital Discloses Disposal of Investment in Black Iron Inc.

PAN GLOBAL GRANTS INCENTIVE AWARDS

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Coelacanth Energy

Coelacanth Energy (CEI:CC)

CEI:CC

One Bullion: Advancing District-scale Gold Assets Across Botswana’s Greenstone Belts

OBUL:CC

Canada One Mining

Canada One Mining (CONE:CC)

CONE:CC

One Bullion Limited

One Bullion Limited (OBUL:CC)

OBUL:CC

ILC Critical Minerals

ILC Critical Minerals (ILC:CC)

ILC:CC

Torrent Capital

Torrent Capital (TORR:CC)

TORR:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES